Keyphrases
Cisplatin Resistance
100%
Gastric Cancer
100%
Expression Synthesis
100%
Glutathione Synthesis
100%
Growth Differentiation factor-15 (GDF-15)
100%
Chemoresistance
33%
Human Gastric Cancer Cells
33%
GFRAL
22%
Via Resistance
11%
Intracellular Glutathione
11%
Clinical Samples
11%
Cisplatin
11%
Chemotherapy
11%
East Asia
11%
Regulatory Mechanism
11%
Serum Levels
11%
Antioxidant Activity
11%
Prognosis Prediction
11%
Treatment Methods
11%
Gastric Cancer Cells
11%
Common Cancers
11%
Promising Treatment
11%
Gastric Cancer Progression
11%
GCN2
11%
Activating Transcription Factor 4 (ATF4)
11%
Malignant Progression
11%
Adjuvant Therapy
11%
Gastric Tumor
11%
Genetic Database
11%
Glial Cell Line-derived Neurotrophic Factor
11%
Mitochondrial GSH
11%
GSH Content
11%
Palliative Therapy
11%
EIF2
11%
Cystine Uptake
11%
Uptake Transporter
11%
Medicine and Dentistry
Upregulation
100%
Cisplatin
100%
Glutathione Metabolism
100%
Abdominal Cancer
100%
Cancer Cell
36%
Drug Resistance
27%
Malignant Neoplasm
9%
Biological Marker
9%
Cancer
9%
Cancer Growth
9%
Receptor
9%
Glutathione
9%
Antioxidant Capacity
9%
Receptor Family
9%
Stomach Tumor
9%
Glial Cells
9%
Neurotrophic Factor
9%
Initiation Factor 2
9%
Cystine
9%
Biochemistry, Genetics and Molecular Biology
Upregulation
100%
Cisplatin
100%
Glutathione Metabolism
100%
Growth Differentiation Factor
100%
Cancer Cell
44%
Drug Resistance
33%
Anabolism
22%
Blood Level
11%
Antioxidant Activity
11%
ATF4
11%
Genetic Database
11%
Neurotrophic Factor
11%
Cystine
11%
Glutathione
11%
Pharmacology, Toxicology and Pharmaceutical Science
Glutathione
100%
Cisplatin
100%
Abdominal Cancer
100%
Drug Resistance
27%
Receptor
18%
Malignant Neoplasm
9%
Chemotherapy
9%
Cancer Growth
9%
Antioxidant Capacity
9%
Biological Marker
9%
Stomach Tumor
9%
Initiation Factor 2
9%
Cystine
9%
Neurotrophic Factor
9%